Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002).
Saved in:
| Title: | Neoadjuvant transarterial chemoembolization with tyrosine kinase and immune checkpoint inhibitors improves survival from resectable hepatocellular carcinoma in a multicenter, retrospective study (GUIDANCE002). |
|---|---|
| Authors: | Yang DL; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Qin C; Department of Hepatobiliary Surgery, Liuzhou People's Hospital, Liuzhou, China., Peng N; Department of Hepatobiliary Surgery, First Affiliated Hospital of Guangxi Medical University, Nanning, China., Liu SP; Department of Hepatobiliary and Pancreatic Surgery, Eighth Affiliated Hospital of Guangxi Medical University, Guigang, China., Yu YQ; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China., Nong JL; Department of Hepatobiliary Surgery, Hengzhou City People's Hospital, Hengzhou, China., Zeng FJ; Department of Hepatobiliary Surgery, Wuzhou Red Cross Hospital, Wuzhou, China., Su Z; Department of Hepatobiliary Pancreatic Surgery, First People's Hospital of Nanning, Nanning, China., Yang YY; Department of Hepatobiliary, Pancreatic and Spleen Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China., Yang FQ; Department of Hepatobiliary and Pancreatic Surgery, First People's Hospital of Yulin, Yulin, China., Li MJ; Department of Hepatobiliary Pancreatic Surgery, Guilin People's Hospital, Guilin, China., Wu MS; Department of Oncology, People's Hospital of Beiliu, Beiliu, China., Wang XY; Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital of Guilin Medical University, Guilin, China., Liang YR; Department of Hepatobiliary and Pancreatic Surgery, First People's Hospital of Qinzhou, Qinzhou, China., Li FX; Department of Hepatobiliary, Pancreatic and Spleen Surgery, People's Hospital of Hezhou, Hezhou, China., Chen SC; Department of Hepatobiliary Surgery, Wuzhou People's Hospital, Wuzhou, China., Lai YC; Department of Hepatobiliary Gland Surgery, Beihai People's Hospital, Beihai, China., Pang QQ; Department of Oncology, Liuzhou Workers Hospital, Liuzhou, China., Zhong TM; Department of Hepatobiliary Surgery, Baise People's Hospital, Baise, China., Yan YH; Department of General Surgery, Second Affiliated Hospital of Guangxi Medical University, Nanning, China., Zhang YY; Department of Hepatobiliary Surgery, Liuzhou People's Hospital, Liuzhou, China., Ye L; Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Guilin Medical University, Guilin, China., Dong XF; Department of Hepatobiliary, Pancreatic and Spleen Surgery, People's Hospital of Guangxi Zhuang Autonomous Region, Guangxi Academy of Medical Sciences, Nanning, China., Li WF; Department of Hepatobiliary and Pancreatic Surgery, First People's Hospital of Yulin, Yulin, China., Liu J; Department of Hepatobiliary Pancreatic Surgery, Guilin People's Hospital, Guilin, China., Yao HB; Department of Hepatobiliary and Pancreatic Surgery, Second Affiliated Hospital of Guilin Medical University, Guilin, China., Wu PS; Department of Hepatobiliary and Pancreatic Surgery, First People's Hospital of Qinzhou, Qinzhou, China., Mao XS; Department of Hepatobiliary, Pancreatic and Spleen Surgery, People's Hospital of Hezhou, Hezhou, China., Ou JJ; Department of Hepatobiliary Surgery, Wuzhou People's Hospital, Wuzhou, China., Chen YZ; Department of Hepatobiliary Gland Surgery, Beihai People's Hospital, Beihai, China., Wang GD; Department of Oncology, Liuzhou Workers Hospital, Liuzhou, China., Chen K; Department of General Surgery, Second Affiliated Hospital of Guangxi Medical University, Nanning, China., Deng ZJ; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Su JY; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Qiu GG; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Liu ZD; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Wang JM; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Zhang Y; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Liang XM; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Xiang BD; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Ma L; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China., Zhong JH; Department of Hepatobiliary Surgery, Guangxi Medical University Cancer Hospital, Nanning, China. zhongjianhong@gxmu.edu.cn. |
| Corporate Authors: | GUIDANCE investigators |
| Source: | Communications medicine [Commun Med (Lond)] 2026 Mar 12; Vol. 6 (1). Date of Electronic Publication: 2026 Mar 12. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Portfolio Country of Publication: England NLM ID: 9918250414506676 Publication Model: Electronic Cited Medium: Internet ISSN: 2730-664X (Electronic) Linking ISSN: 2730664X NLM ISO Abbreviation: Commun Med (Lond) Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
